Diagonal Therapeutics logo

Diagonal Therapeutics Funding & Investors

Cambridge, MA

Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles associated with agonist antibody drug development.

diagonaltx.com

Total Amount Raised: $128,000,000

Diagonal Therapeutics Funding Rounds

  • Series A

    $128,000,000

    Series A Investors

    Atlas Venture
    BVF Partners
    Lightspeed Venture Partners
    Frazier Life Sciences
    Viking Global Investors
    Checkpoint Capital
    Ra Capital Management
    Velosity Capital
Funding info provided by Diffbot.